LifeMD (LFMD) Research & Development (2019 - 2025)

LifeMD (LFMD) has reported Research & Development for 7 consecutive years, with -$1.7 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Research & Development rose 75.65% year-over-year to -$1.7 million; the trailing twelve-month figure through Dec 2025 stood at $86.1 million (up 22.78% YoY), and the FY2025 full-year result was $86.1 million, up 22.78% from the prior year.
• Research & Development slipped to -$1.7 million in Q4 2025 per LFMD's latest filing, from $29.5 million in the prior quarter.
• Across five years, Research & Development topped out at $29.5 million in Q3 2025 and bottomed at -$7.1 million in Q4 2024.
• Historically, Research & Development has averaged $19.7 million across 5 years, with a median of $20.8 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Research & Development jumped 578.86% in 2021, then slumped 134.63% in 2024.
• Over 5 years, Research & Development stood at $21.2 million in 2021, then decreased by 17.61% to $17.4 million in 2022, then climbed by 16.9% to $20.4 million in 2023, then plunged by 134.63% to -$7.1 million in 2024, then jumped by 75.65% to -$1.7 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered -$1.7 million, $29.5 million, and $29.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.